Form: S-8

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 5, 2017

 

Exhibit 5.1

 

11693 San Vicente Boulevard

Suite 357

Los Angeles, California 90049

310-207-0665

   

www.seclawfirm.com

Writer’s direct dial:
  310-557-3059

 

 

May 5, 2017

 

Apollo Medical Holdings, Inc.

700 North Brand Boulevard. Suite 1400

Glendale, California 91203

 

Re: Apollo Medical Holdings, Inc. Registration Statement on Form S-8

 

Ladies and Gentlemen:

 

We have acted as counsel for Apollo Medical Holdings, Inc., a Delaware corporation (the “Company”), in connection with the preparation and filing with the Securities and Exchange Commission (the “Commission”) of the Company’s Registration Statement on Form S-8 (the “Registration Statement”), under the Securities Act of 1933, as amended (the “Securities Act”), relating to the registration of an aggregate of 2,497,500 shares of the Company’s common stock, par value $0.001 per share (the “Shares”), reserved for issuance pursuant to the Company’s 2010 Equity Incentive Plan and 2015 Equity Incentive Plan (collectively, the “Plans”). As your legal counsel, we have reviewed the actions proposed to be taken by you in connection with the issuance and sale of the Shares to be issued under the Plans.

 

In connection with this opinion, we have examined originals or copies, certified or otherwise identified to our satisfaction, of (i) the Restated Certificate of Incorporation of the Company, (ii) the Restated Bylaws of the Company, (iii) the Registration Statement, (iv) the Plans, and (v) such corporate records, agreements, documents and other instruments, and such certificates or comparable documents of public officials and of officers and representatives of the Company, and have made such inquiries of such officers and representatives, as we have deemed relevant and necessary or appropriate as a basis for the opinion set forth below.

 

In our examination, we have assumed the legal capacity of all natural persons, the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as facsimile, electronic, certified or photostatic copies, and the authenticity of the originals of such copies. In making our examination of documents executed or to be executed, we have assumed that the parties thereto, other than the Company, had or will have the power, corporate or other, to enter into and perform all obligations thereunder and have also assumed the due authorization by all requisite action, corporate or other, and the execution and delivery by such parties of such documents and the validity and binding effect thereof on such parties. As to any facts material to the opinions expressed herein that we did not independently establish or verify, we have relied upon statements and representations of officers and other representatives of the Company and others and of public officials.

 

Based on the foregoing and subject to the limitations, qualifications and assumptions set forth herein, we are of the opinion that the Shares to be issued pursuant to the terms of the respective Plans have been duly authorized and, when issued, delivered and paid for in accordance with the terms of the respective Plans, will be validly issued, fully paid and non-assessable.

 

 

 

Apollo Medical Holdings, Inc.

May 5, 2017

Page Two

 

 

The opinion expressed herein is limited to the corporate laws of the State of Delaware and the federal laws of the United States of America, and we express no opinion as to the effect on the matters covered by this letter of the laws of any other jurisdictions.

 

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement. In giving such consent, we do not hereby admit that we are included in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder.

 

Very truly yours,

 

 

/s/ Lance Jon Kimmel

 

Lance Jon Kimmel

 

 

SEC LAW FIRM 11693 San Vicente Boulevard, Suite 357 Los Angeles, CA 90049

Tel. 310-207-0665 Fax. 310-388-1320

www.seclawfirm.com